How big is the Intravenous Solutions Market?

The Intravenous Solutions Market size is expected to reach USD 13.27 billion in 2024 and grow at a CAGR of 5.49% to reach USD 17.33 billion by 2029. Read More

What is the current Intravenous Solutions Market size?

In 2024, the Intravenous Solutions Market size is expected to reach USD 13.27 billion. Read More

Who are the key players in Intravenous Solutions Market?

Ajinomoto, B. Braun SE, Baxter International, Grifols and ICU Medical Inc. are the major companies operating in the Intravenous Solutions Market. Read More

Which is the fastest growing region in Intravenous Solutions Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Intravenous Solutions Market?

In 2024, the North America accounts for the largest market share in Intravenous Solutions Market. Read More

What years does this Intravenous Solutions Market cover, and what was the market size in 2023?

In 2023, the Intravenous Solutions Market size was estimated at USD 12.54 billion. The report covers the Intravenous Solutions Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Intravenous Solutions Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Intravenous Solutions Market Share

Statistics for the 2023 & 2024 Intravenous Solutions market share, created by Mordor Intelligence™ Industry Reports. Intravenous Solutions share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Intravenous Solutions Industry

The intravenous solutions market is competitive due to the presence of companies operating internationally and regionally. These market participants are undertaking several organic and inorganic growth strategies to capture a higher revenue share in this industry. Some of the major players include Ajinomoto, B. Braun SE, Baxter International, Grifols, and ICU Medical Inc.